Catalina Alamón

发表

Discovery of Potent EGFR Inhibitors through the Incorporation of a 3D-Aromatic-Boron-Rich-Cluster into the 4-Anilinoquinazoline Scaffold: Potential Drugs for Glioma Treatment.

F. Teixidor, C. Viňas, Pablo Cabral, 2018, Chemistry.

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity

M. Gavish, L. Barbeito, F. Teixidor, 2020, Cancers.

PD-1/PD-L1 blockade abrogates a dysfunctional innate-adaptive immune axis in critical β-coronavirus disease

L. Barbeito, D. Olivera, P. Moraes-Vieira, 2022, Science advances.

Carboranylanilinoquinazoline EGFR-inhibitors: toward 'lead-to-candidate' stage in the drug-development pipeline.

F. Teixidor, C. Viňas, Marcelo Fernández, 2019, Future medicinal chemistry.

The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS

L. Barbeito, O. Hermine, P. King, 2021, Acta neuropathologica communications.

Bimodal Therapeutic Agents against Glioblastoma, one of the most Lethal Cancer.

M. Perona, F. Teixidor, C. Viňas, 2020, Chemistry.

Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

S. Thorp, P. Curotto, E. Pozzi, 2020, Cells.

Substrate Recognition Properties from an Intermediate Structural State of the UreA Transporter

S. Pantano, S. Amillis, M. Sanguinetti, 2022, International journal of molecular sciences.

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration.

Abraham Weizman, M. Gavish, S. Thorp, 2023, Molecular pharmaceutics.